新冠肺炎長期綜合後遺症是指新冠病毒感染後長期持續而影響多個器官的症狀，又稱「長新冠」。長新冠影響全球超過6,500萬人，但仍缺乏有效的治療方法。香港中文大學醫學院的研究團隊完成了一項大型的雙盲、隨機、安慰劑對照臨床研究，證實患者透過服用香港中文大學研發的口服合生製劑（SIM01）有效紓緩多種長新冠症狀…
Blog
-
Gut Microbiota Modulation for Post-Acute COVID-19 Syndrome: Current Evidence
Post-acute COVID-19 syndrome (“long COVID”) refers to long-term symptoms that persist after acute SARS-CoV-2 infection, affecting multiple organs and systems. Long COVID affects over 65 million people worldwide, yet effective treatment is limited. Our research team at the Faculty of Medicine of the Chinese University of Hong Kong (CUHK Medicine) has completed a large-scale double-blind, randomised, placebo-controlled clinical trial, which confirmed that patients who were given an oral synbiotic preparation (SIM01) developed by CUHK experienced significant alleviation in various long COVID symptoms…
-
Alpacas and Nanobodies
When we think of alpacas, the first things that pop up in our minds may be holiday farms or alpaca fleece. However, if you ask a biomedical scientist, they may have thought of nanobody, fragment of a special type of antibody…
-
Alpacas and Nanobodies
When we think of alpacas, the first things that pop up in our minds may be holiday farms or alpaca fleece. However, if you ask a biomedical scientist, they may have thought of nanobody, fragment of a special type of antibody…
